Found 1311 bookmarks
Newest
Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity - J S Hui-Yuen, Y Gartshteyn, M Ma, T O’Malley, J Conklin, A H Eichenfield, L F Imundo, T Dervieux, A D Askanase, 2018
Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity - J S Hui-Yuen, Y Gartshteyn, M Ma, T O’Malley, J Conklin, A H Eichenfield, L F Imundo, T Dervieux, A D Askanase, 2018
Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity - J S Hui-Yuen, Y Gartshteyn, M Ma, T O’Malley, J Conklin, A H Eichenfield, L F Imundo, T Dervieux, A D Askanase, 2018
COVID-19 Impact on Hybrid Fiber Coaxial Network Market Size 2021 by Share And Forecast 2028 | Arris, Huawei, Nokia, Technicolor, Cisco, Ciena, Commscope, PCT International, ZTE, Comba, Skyworks, Vecima Networks, Technetix, Infinera, Bentley Systems, Bk
COVID-19 Impact on Hybrid Fiber Coaxial Network Market Size 2021 by Share And Forecast 2028 | Arris, Huawei, Nokia, Technicolor, Cisco, Ciena, Commscope, PCT International, ZTE, Comba, Skyworks, Vecima Networks, Technetix, Infinera, Bentley Systems, Bk
COVID-19 Impact on Hybrid Fiber Coaxial Network Market Size 2021 by Share And Forecast 2028 | Arris, Huawei, Nokia, Technicolor, Cisco, Ciena, Commscope, PCT International, ZTE, Comba, Skyworks, Vecima Networks, Technetix, Infinera, Bentley Systems, Bk
https://www.google.com/url?cd=&esrc=s&q=&rct=j&sa=t&source=web&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20110629005531%2Fen%2FInternational-Stem-Cell%25E2%2580%2599s-Lifeline-Cell-Technology-Subsidiary-Expands-Sales-and-Distribution-While-Enhancing-Manufacturing-Capability-and-Clinical-Product-Opportunities&usg=AOvVaw17zTEf2aKC-dzFP0xWKONu&ved=2ahUKEwijjqz4wufxAhWFZs0KHaCVDLM4HhAWegQIBxAA
https://www.google.com/url?cd=&esrc=s&q=&rct=j&sa=t&source=web&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20110629005531%2Fen%2FInternational-Stem-Cell%25E2%2580%2599s-Lifeline-Cell-Technology-Subsidiary-Expands-Sales-and-Distribution-While-Enhancing-Manufacturing-Capability-and-Clinical-Product-Opportunities&usg=AOvVaw17zTEf2aKC-dzFP0xWKONu&ved=2ahUKEwijjqz4wufxAhWFZs0KHaCVDLM4HhAWegQIBxAA
https://www.google.com/url?cd=&esrc=s&q=&rct=j&sa=t&source=web&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20110629005531%2Fen%2FInternational-Stem-Cell%25E2%2580%2599s-Lifeline-Cell-Technology-Subsidiary-Expands-Sales-and-Distribution-While-Enhancing-Manufacturing-Capability-and-Clinical-Product-Opportunities&usg=AOvVaw17zTEf2aKC-dzFP0xWKONu&ved=2ahUKEwijjqz4wufxAhWFZs0KHaCVDLM4HhAWegQIBxAA